Sage Therapeutics Inc. buy Needham & Company LLC
Start price
07.08.23
/
50%
€17.80
Target price
07.08.24
€63.64
Performance (%)
-57.02%
End price
08.08.24
€7.65
Summary
This prediction ended on 08.08.24 with a price of €7.65. The BUY prediction by Needham___Company_LL for Sage Therapeutics Inc. performed very badly with a performance of -57.02%. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Sage Therapeutics Inc. | -1.652% | -1.652% | -66.603% |
iShares Core DAX® | -1.471% | 1.895% | 25.178% |
iShares Nasdaq 100 | -0.486% | 4.395% | 29.415% |
iShares Nikkei 225® | -2.115% | 2.450% | 20.561% |
iShares S&P 500 | 0.394% | 3.118% | 29.456% |
Comments by Needham___Company_LL for this prediction
In the thread Sage Therapeutics Inc. diskutieren
Sage Therapeutics, Inc. (NASDAQ: SAGE) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $70.00 price target on the stock.
Ratings data for SAGE provided by MarketBeat
In the thread Trading Sage Therapeutics Inc.
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten